Qualigen Therapeutics Inc QLGN
$3.21 $0.17 (5.59%) 1D
Last Updated: Nov 18, 12:00 AM·XDUS
Pricing for DE stocks is delayed by 24 hours
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
Pricing
Company
About Musaffa
Investors
Build with us
Is Qualigen Therapeutics Inc Stock Halal?
Shariah Compliance Analysis of QLGN Stock
Germany Health Care Nano Cap No. As of September 2026, Qualigen Therapeutics Inc (QLGN) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Qualigen Therapeutics Inc does not pass Musaffa's business and financial screening criteria.
Qualigen Therapeutics, Inc. is a biotechnology company focused on developing therapeutics for the treatment of cancer and infectious diseases. The company is headquartered in Carlsbad, California and currently employs 4 full-time employees. The company went IPO on 2015-06-24. The firm is focused on developing treatments for adult and pediatric cancers. The Company’s business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program (Pan-RAS). Its lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells (such as pancreatic cancer). Its Pan-RAS program, which is at the preclinical stage, consists of a family of rat sarcoma virus (RAS) oncogene protein-protein interaction inhibitor small molecules inhibits or block mutated RAS genes’ proteins from binding to their effector proteins thereby leaving the proteins from the mutated RAS unable to cause further harm. Its QN-302 is in a Phase 1a clinical trial.
QLGN Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, Qualigen Therapeutics Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Qualigen Therapeutics Inc (QLGN) Chart
Financial Metrics & Statements of Qualigen Therapeutics Inc (QLGN)
FAQ's for Qualigen Therapeutics Inc (QLGN)
- As of September 2026, Qualigen Therapeutics Inc QLGN is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Qualigen Therapeutics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Qualigen Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Qualigen Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Qualigen Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Qualigen Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Qualigen Therapeutics Inc (QLGN)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
